Pharmaceuticals Top 5 Emerging Markets Industry Guide 2013-2022
June 2018
143
About the Report
About the Report
Pharmaceuticals Top 5 Emerging Markets Industry Guide 2013-2022
Summary
The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the emerging five pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Key Highlights
- These countries contributed USD 196.5 billion to the global pharmaceuticals industry in 2017, with a compound annual growth rate (CAGR) of 8.4% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of USD 309.3 billion in 2022, with a CAGR of 9.5% over the 2017-22 period.
- Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of USD 108.3 billion in 2017. This was followed by India and Brazil with a value of USD 35.2 and USD 26.1 billion, respectively.
- China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of USD 173.1 billion in 2022, followed by India and Brazil with expected values of USD 70.2 and USD 31.0 billion, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players' emerging five operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
- Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to buy
- What was the size of the emerging five pharmaceuticals market by value in 2017?
- What will be the size of the emerging five pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the emerging five pharmaceuticals market?
Products
Companies
Table of Contents
Table of Contents
Table of Contents
Introduction 11
What is this report about? 11
Who is the target reader? 11
How to use this report 11
Definitions 11
Top 5 Emerging Countries Pharmaceuticals 12
Industry Outlook 12
Pharmaceuticals in South Africa 15
Market Overview 15
Market Data 16
Market Segmentation 17
Market outlook 19
Five forces analysis 20
Macroeconomic indicators 29
Pharmaceuticals in Brazil 31
Market Overview 31
Market Data 32
Market Segmentation 33
Market outlook 35
Five forces analysis 36
Macroeconomic indicators 44
Pharmaceuticals in China 46
Market Overview 46
Market Data 47
Market Segmentation 48
Market outlook 50
Five forces analysis 51
Macroeconomic indicators 60
Pharmaceuticals in India 62
Market Overview 62
Market Data 63
Market Segmentation 64
Market outlook 66
Five forces analysis 67
Macroeconomic indicators 77
Pharmaceuticals in Mexico 79
Market Overview 79
Market Data 80
Market Segmentation 81
Market outlook 83
Five forces analysis 84
Macroeconomic indicators
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.